Want to see TSE:DOCT full AI Analyst Report?
DOCT Stock Chart & Stats
C$0.17
C$0.01(8.70%)
At close: 4:00 PM EDT
C$0.17
C$0.01(8.70%)
Day’s Range― - ―
52-Week RangeC$0.11 - C$0.57
Previous CloseN/A
Volume1.00K
Average Volume (3M)1.71K
Market Cap
C$5.74M
Enterprise ValueC$13.67M
Total Cash (Recent Filing)C$1.81M
Total Debt (Recent Filing)C$11.38M
Price to Earnings (P/E)―
Beta1.22
Next Earnings
Nov 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding32,793,960
10 Day Avg. Volume938
30 Day Avg. Volume1,706
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)45.96
Price to Sales (P/S)534.40
P/FCF Ratio-3.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Healthcare Technology FocusThe stated focus on medical and healthcare-related technology places the company within an industry tied to ongoing healthcare needs and technology adoption. This provides a potentially relevant business domain over the medium term, although the pack does not establish commercial traction or a competitive advantage.
Positive TTM Free Cash Flow GrowthPositive reported free cash flow growth in the TTM period indicates improvement in the direction of cash generation compared with the prior period. However, the absolute free cash flow level remains negative, so this is an early operational improvement rather than evidence of self-sustaining cash generation.
Prior Positive Equity BaseThe annual 2025 equity base shows that the company previously maintained some shareholder capital before equity turned negative in the TTM period. That history indicates the balance sheet was not always structurally impaired, though the subsequent deterioration substantially reduces the practical benefit of this earlier position.
Bears Say
Severely Weak Revenue And ProfitabilityVery small and sharply deteriorating revenue indicates limited commercial traction and leaves the company with little operating scale. Persistent large operating and net losses further weaken earnings quality, making profitability difficult to sustain without a substantial improvement in sales or cost structure.
Persistent Cash BurnNegative operating cash flow across every reported period shows that core operations have not funded themselves, while negative free cash flow confirms continuing cash burn. Reliance on external funding can constrain investment, increase financing pressure, and reduce the company’s ability to withstand operating setbacks.
Stressed Leverage And Negative EquityDebt far exceeding the equity base, combined with negative TTM equity, signals severe balance-sheet stress and limited financial flexibility. Declining assets add to the concern, while refinancing and potential dilution risk may restrict strategic choices and make funding ongoing operations more difficult.
Beyond Medical Technologies Inc News
DOCT FAQ
What was Beyond Medical Technologies Inc’s price range in the past 12 months?
Beyond Medical Technologies Inc lowest stock price was C$0.10 and its highest was C$0.57 in the past 12 months.
What is Beyond Medical Technologies Inc’s market cap?
Beyond Medical Technologies Inc’s market cap is C$5.74M.
When is Beyond Medical Technologies Inc’s upcoming earnings report date?
Beyond Medical Technologies Inc’s upcoming earnings report date is Nov 26, 2026 which is in 47 days.
How were Beyond Medical Technologies Inc’s earnings last quarter?
Beyond Medical Technologies Inc released its earnings results on May 04, 2026. The company reported -C$0.097 earnings per share for the quarter.
Is Beyond Medical Technologies Inc overvalued?
According to Wall Street analysts Beyond Medical Technologies Inc’s price is currently Overvalued.
Does Beyond Medical Technologies Inc pay dividends?
Beyond Medical Technologies Inc does not currently pay dividends.
What is Beyond Medical Technologies Inc’s EPS estimate?
Beyond Medical Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beyond Medical Technologies Inc have?
Beyond Medical Technologies Inc has 32,793,960 shares outstanding.
What happened to Beyond Medical Technologies Inc’s price movement after its last earnings report?
Beyond Medical Technologies Inc reported an EPS of -C$0.097 in its last earnings report. Following the earnings report the stock price went up 8.824%.
Which hedge fund is a major shareholder of Beyond Medical Technologies Inc?
Currently, no hedge funds are holding shares in TSE:DOCT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Beyond Medical Technologies Inc
Republic Technologies Inc. provides Ethereum-based technology services. The company develops Validity Network, an attestation platform that provides cryptographically secure and tamper-resistant assurances of data integrity by anchoring data commitments directly onto the Ethereum blockchain. It also engages in synthetic mining and validator infrastructure operations. The company was formerly known as Beyond Medical Technologies Inc. and changed its name to Republic Technologies Inc. in July 2025. Republic Technologies Inc. is based in Vancouver, Canada.